Barclays »

Repare Therapeutics Ord shares owned by Barclays

Quarter-by-quarter ownership of Repare Therapeutics Ord (RPTX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Repare Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Repare Therapeutics Ord held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Repare Therapeutics Ord by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.0k 530 7.55
2023-09-30 $49k 4.1k 12.09
2023-06-30 $36k 3.4k 10.56
2022-03-31 $999 77 12.99

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Repare Therapeutics Ord

BVF
OrbiMed Advisors
Blue Owl Capital Holdings
ARK Investment Management
Versant Venture Management
Redmile Group
Artal Group
Aquilo Capital Management
Logos Global Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Millennium Management
GSA Capital Partners
Bank Of Montreal
D. E. Shaw & Co

View all funds holding Repare Therapeutics Ord